Full Spectral Freedom for Multi-color Deep Tissue In Vivo Imaging

Multicolor image of a Confetti Mouse recorded with the new SP8 DIVE with the 4Tune spectral detector. The adaptation to the transgenic markers allows to achieve more contrast and depth for multi-color in vivo deep imaging. Sample courtesy of Jacco van Rheenen. University of Utrecht, NL Mannheim, Germany. The ability to visualize complex biological processes... Read more

Effective Analysis of Elemental Impurities in Pharmaceuticals Using EDX Fluorescence Spectrometry Release of the Pharmaceuticals Impurities Analysis Method Package

Analysis with the EDX-7000 can be started by putting the sample in the special container and placing it in the instrument. There is no need to chemically pretreat the sample. Special gases and vacuum conditions are unnecessary, and since it operates on household power supply, installation is easy. In addition, by incorporating two kinds of... Read more

Roka Bioscience to participate in the 40th Annual National Food Policy Conference

Roka Bioscience to participate in the 40th Annual National Food Policy Conference WARREN, N.J., April 10, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced today that Dr. Erin Dreyling, Vice President, Research & Scientific Affairs at Roka Bioscience... Read more

GE Healthcare acquires Asymptote for complete, digitally-enabled cryogenic cold chain technology supporting safe manufacture and delivery of cellular therapies

Chalfont St Giles, UK – 11 April 2017 – GE Healthcare has acquired Asymptote Limited, specialists in cryochain technology for sensitive cellular therapies. Asymptote’s integrated suite of cryochain hardware, software and consumables are designed to maintain the potency of cellular therapies enabling ultra-low temperature freezing during production, all the way to thawing at the clinic... Read more

2016: A Strong Year for the Greiner Group (copy 1)

The Greiner Group once again improved its sales figures and reached its financial targets in the business year 2016. Besides globalization, diversification and innovation as the key factors of success, the “Plastics for Life” sustainability strategy is at the center of activities. Kremsmünster, May 3, 2017 – The Greiner Group improved its consolidated sales revenues... Read more

Greiner Bio-One North America, Inc. Announces the Launch of the Global Summit for Best Practices in Preanalytics

Greiner Bio-One North America, Inc. is proud to announce an agreement has been reached to name Greiner Bio-One the new provider of the popular educational event, The Global Summit on Best Practices in Preanalytics, formerly The Phlebotomy Supervisor’s Boot Camp™. Starting in 2017, the Phlebotomy Supervisor’s Boot Camp™ will be known as the Global Summit... Read more

GE Healthcare invests in Zenith Technologies, the companies to deliver together next-generation of biopharma automation

CHALFONT ST. GILES, UK and CORK, IRELAND – 11 April 2017 – Zenith Technologies and GE Healthcare Life Sciences announce today that GE has completed a strategic minority investment in Irish-owned Zenith Technologies, a leading technology company delivering manufacturing software systems and solutions for the life sciences industry. This enhancement of the existing partnership brings... Read more

Illumina Launches the VeriSeq™ NIPT Solution in Europe

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the VeriSeq™ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT), including CE-IVD marked library prep and analysis software, which enables laboratories in the European Union to bring efficient, highly accurate NIPT in-house. The automated comprehensive solution allows laboratories... Read more

Phase III study shows Roche’s Alecensa was superior to crizotinib in a specific type of lung cancer

Basel, 10 April 2017 Phase III study shows Roche’s Alecensa was superior to crizotinib in a specific type of lung cancer Second Phase III head-to-head study that showed that Alecensa helped people with advanced ALK-positive non-small cell lung cancer (NSCLC) Results showed that people treated with Alecensa lived significantly longer without their disease progressing compared... Read more